India’s Desire: World’s Future Source for Biotech Appetite

In its biotechnology industry India is a proud contributor of more than $700 million in annual revenues. With a growth of 40% over the past year, she is second only to United States in the total number of FDA-approved drug manufacturing plants. The various factors accounting for India’s blossoming biotechnology industry are skilled laborers, low costs, new patent protections and a pool of patients ready for clinical trials. Indian companies are ready learners with its good number of educated scientists. India therefore stands as a good destination for manufacturers and marketers. Several European companies and US are prompted to set up their units in this country. They also contemplate on forming contracts with Indian firms for drug-development research, clinical t View the rest of this article